CLC Number:

[1]	XIA Qing, DAI Xing-ling, WANG Ru-tao. Clinical evaluation of efficacy of fluticasone propionate/salmeterol in treatment of mild to moderate asthma [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(6): 702-705.
[2]	QIN Dong-Yun, LIANG Biao. Therapeusis of arsenic trioxide on asthma in mice and its possible mechanisms [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(4): 430-433.
[3]	ZHANG Hong-Quan, ZHOU Cheng-Hua, WU Yu-Qing. Effects of bambuterol on expression of nuclear factor-kappa B of lymphocytes in asthmatic guinea pigs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(3): 285-288.
[4]	. [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(4): 374-377.
[5]	ZHANG Jing-Bo, JI Yan-Yan. Variation of asthma patient’s qual ity of life after anti-inflammation treatment [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(3): 231-234.
[6]	. [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(4): 305-306.
[7]	. [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(1): 68-69.

PDF (PC)

Knowledge